A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
1 other identifier
observational
400
1 country
68
Brief Summary
The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to inform CF research, help design CF clinical trials and support the development of new treatments for people with CF who do not take CFTR modulators. Another goal of this study is to learn about research involvement for people with CF who do not take CFTR modulators, engage them in research, and give them an opportunity to learn about what is involved in participating in a CF research study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Longer than P75 for all trials
68 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedStudy Start
First participant enrolled
September 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 14, 2029
October 1, 2025
September 1, 2025
4.9 years
June 27, 2024
September 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in ppFEV1 at 12 months
Mean change (standard deviation) in percent predicted forced expiratory volume in 1 second (ppFEV1) as measured by in-clinic spirometry from baseline to 12 months post-baseline.
12 months
Secondary Outcomes (6)
Change in CFQ-R-RD at 12 months
12 months
Change in home spirometry ppFEV1 at 12 months
12 months
Change in LCI 2.5% at 12 months
12 months
Change in LCI 5% at 12 months
12 months
Absolute 12-month change in MCC Index
12 months
- +1 more secondary outcomes
Eligibility Criteria
People with CF who are ineligible and/or not taking an approved CFTR modulator and who are not receiving an investigational therapy.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Nicole Hamblettlead
- Washington University School of Medicinecollaborator
- Florida State Universitycollaborator
- University of North Carolina, Chapel Hillcollaborator
- University of Torontocollaborator
- Cystic Fibrosis Foundationcollaborator
Study Sites (68)
The Children's Hospital Alabama, University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
Tucson Cystic Fibrosis Center
Tucson, Arizona, 85724, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of California San Diego
La Jolla, California, 92093, United States
Childrens Hospital Los Angeles
Los Angeles, California, 90027, United States
Stanford University Medical Center
Palo Alto, California, 94304, United States
University of California, San Francisco - Adult Center
San Francisco, California, 94143, United States
University of California, San Francisco - Peds Center
San Francisco, California, 94158, United States
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
National Jewish Health
Denver, Colorado, 80206, United States
University of Florida
Gainesville, Florida, 32610, United States
University of Miami
Miami, Florida, 33136, United States
Central Florida Pulmonary Group
Orlando, Florida, 32803, United States
Tampa General Hospital
Tampa, Florida, 33606, United States
Children's Healthcare of Atlanta and Emory University
Atlanta, Georgia, 30329, United States
Augusta University
Augusta, Georgia, 30912, United States
Saint Luke's Cystic Fibrosis Center of Idaho
Boise, Idaho, 83702, United States
Northwestern University
Chicago, Illinois, 60611, United States
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
University of Kentucky
Lexington, Kentucky, 40506, United States
Tulane University
Metairie, Louisiana, 70001, United States
John Hopkins Hospital
Baltimore, Maryland, 21287, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Health Care
Worcester, Massachusetts, 01655, United States
University of Michigan, Michigan Medicine
Ann Arbor, Michigan, 48109, United States
Wayne State University Harper University Hospital
Detroit, Michigan, 48201, United States
Corewell Health Helen DeVos
Grand Rapids, Michigan, 49503, United States
The Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota, 55455, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Billings Clinic
Billings, Montana, 59101, United States
University of Nebraska Medical Center
Omaha, Nebraska, 69198, United States
Morristown Medical Center
Morristown, New Jersey, 07960, United States
The Cystic Fibrosis Center of Western New York
Buffalo, New York, 14203, United States
Cohen Children's Medical Center of New York
New Hyde Park, New York, 11042, United States
Columbia University Cystic Fibrosis Program
New York, New York, 10032, United States
University of Rochester Medical Center Strong Memorial
Rochester, New York, 14642, United States
New York Medical College at Westchester Medical Center
Valhalla, New York, 10595, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Cleveland Clinic Cystic Fibrosis Program
Cleveland, Ohio, 44195, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Dayton Children's Hospital
Dayton, Ohio, 45404, United States
Oregon Health & Sciences University
Portland, Oregon, 97239, United States
Hershey Medical Center Pennsylvania State University
Hershey, Pennsylvania, 17033, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15224, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Prisma Health Children's Hospital - Midlands
Columbia, South Carolina, 29203, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
University of Texas Southwestern / Children's Health
Dallas, Texas, 75207, United States
University of Texas Southwestern
Dallas, Texas, 75390, United States
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
Adult Cystic Fibrosis Center at the University of Utah
Salt Lake City, Utah, 84112, United States
Inova L.J. Murphy Pediatric CF Program
Fairfax, Virginia, 22031, United States
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
Seattle Children's Hospital
Seattle, Washington, 98105, United States
University of Washington Medical Center
Seattle, Washington, 98195, United States
Providence Medical Group, Cystic Fibrosis Clinic
Spokane, Washington, 99204, United States
West Virginia University - Morgantown
Morgantown, West Virginia, 26507, United States
University of Wisconsin
Madison, Wisconsin, 53792, United States
Biospecimen
Serum, plasma and white blood cells
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deepika Polineni, MD, MPH
Washington University School of Medicine
- PRINCIPAL INVESTIGATOR
Nicole Mayer-Hamblett, PhD
Seattle Children's Hospital
- PRINCIPAL INVESTIGATOR
Scott Donaldson, MD
University of North Carolina, Chapel Hill
- PRINCIPAL INVESTIGATOR
Felix Ratjen, MD
University of Toronto
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Pediatrics, Division of Pulmonary and Sleep Medicine, UW School of Medicine Adjunct Professor, Biostatistics, UW School of Medicine Co-Executive Director, CF Therapeutics Development Network
Study Record Dates
First Submitted
June 27, 2024
First Posted
July 17, 2024
Study Start
September 18, 2024
Primary Completion (Estimated)
August 14, 2029
Study Completion (Estimated)
August 14, 2029
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share